Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12544425 | Methods for preventing and treating brain inflammation | 🖼🧊📄§ | 2026-02-10 | 2044-11-20 | 0 | 31 |
| 12544423 | C3b binding polypeptide | 🖼🧊📄§ | 2026-02-10 | 2042-10-20 | 0 | 31 |
| 12544386 | Method and composition for treatment of skin diseases associated with accelerated corneodesmosomes degradation or weaker cell-cell adhesion | 🖼🧊📄§ | 2026-02-10 | 2040-05-13 | 0 | 31 |
| 12544414 | Lactobacillus reuteri and use, composition, drug and food thereof | 🖼🧊📄§ | 2026-02-10 | 2042-04-13 | 0 | 31 |
| 12544434 | Recombinant lactic acid bacterium and method thereof for simultaneous treatment and/or prevention of dust mite and cockroach allergies | 🖼🧊📄§ | 2026-02-10 | 2043-06-07 | 0 | 31 |
| 12544422 | Use of gelsolin to treat or prevent lung injury and disease | 🖼🧊📄§ | 2026-02-10 | 2040-11-20 | 0 | 31 |
| 12544441 | Compositions comprising CelTOS immunogens and antibodies and method of use thereof | 🖼🧊📄§ | 2026-02-10 | 2043-03-23 | 0 | 31 |
| 12545643 | 3,5-diaminobenzoic acid compound, and Pin1 inhibitor and therapeutic agent for inflammatory diseases using same | 🖼🧊📄§ | 2026-02-10 | 2041-03-09 | 0 | 31 |
| 12545741 | Anti-PD-1 and IL-15/IL-15Ra multifunctional antibody conjugate, preparation for same, and uses thereof | 🖼🧊📄§ | 2026-02-10 | 2040-07-09 | 0 | 31 |
| 12544459 | Methods and means for the prevention and/or treatment of hemophilic arthropathy in hemophilia | 🖼🧊📄§ | 2026-02-10 | 2045-02-06 | 0 | 31 |
| 12545916 | Allele-specific silencing therapy for DFNA9 using antisense oligonucleotides | 🖼🧊📄§ | 2026-02-10 | 2040-10-29 | 0 | 31 |
| 12544351 | Methods using medium chain triglycerides administered prior to a meal to decrease postprandial glucose from the meal | 🖼🧊📄§ | 2026-02-10 | 2040-03-20 | 0 | 31 |
| 12544342 | Pharmaceutical composition containing taxane nanoaggregates and use thereof | 🖼🧊📄§ | 2026-02-10 | 2043-08-04 | 0 | 31 |
| 12544397 | Compositions and methods containing N-acetylcystein and nicotinamide riboside for prevention and treatment of neurological diseases and conditions | 🖼🧊📄§ | 2026-02-10 | 2041-04-01 | 0 | 31 |
| 12545735 | Anti-met antibodies, bispecific antigen binding molecules that bind met, and methods of use thereof | 🖼🧊📄§ | 2026-02-10 | 2041-08-25 | 0 | 31 |
| 12544345 | Compounds and combinations thereof for treating neurological and psychiatric conditions | 🖼🧊📄§ | 2026-02-10 | 2045-06-25 | 0 | 31 |
| 12544392 | Treatment of adenovirus infection or disease associated with adenovirus infection | 🖼🧊📄§ | 2026-02-10 | 2044-12-13 | 0 | 31 |
| 12544400 | Treatment of myopic progression | 🖼🧊📄§ | 2026-02-10 | 2042-12-13 | 0 | 31 |
| 12544444 | Administration of tailored feedstock to increase antibiotic susceptibility | 🖼🧊📄§ | 2026-02-10 | 2039-08-22 | 0 | 31 |
| 12545730 | Optimized anti-CD3 arm in the generation of t-cell bispecific antibodies for immunotherapy | 🖼🧊📄§ | 2026-02-10 | 2040-12-15 | 0 | 31 |
| 12544343 | Treatment of inflammatory condition in mucous membrane or skin | 🖼🧊📄§ | 2026-02-10 | 2040-10-23 | 0 | 31 |
| 12544381 | Topical formulation for JAK inhibitor | 🖼🧊📄§ | 2026-02-10 | 2045-04-05 | 0 | 31 |
| 12544421 | VDAC inhibitors for treating inflammatory bowel diseases | 🖼🧊📄§ | 2026-02-10 | 2039-11-26 | 0 | 31 |
| 12545688 | Camptothecin derivative and conjugate thereof | 🖼🧊📄§ | 2026-02-10 | 2040-09-17 | 0 | 31 |
| 12544420 | Electroporation-targeted delivery of ribosome inactivating protein gelonin into mammalian cells | 🖼🧊📄§ | 2026-02-10 | 2045-03-25 | 0 | 31 |
| 12545712 | C3d cellular and acellular vaccines for the prevention and treatment of cancer | 🖼🧊📄§ | 2026-02-10 | 2041-12-15 | 0 | 31 |
| 12544368 | Compositions and methods for reducing cancer stem cells | 🖼🧊📄§ | 2026-02-10 | 2039-10-15 | 0 | 31 |
| 12544365 | Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumours | 🖼🧊📄§ | 2026-02-10 | 2042-10-26 | 0 | 31 |
| 12545723 | Anti-CSP antibodies | 🖼🧊📄§ | 2026-02-10 | 2043-01-26 | 0 | 31 |
| 12544375 | Small molecule therapeutic for parkinson's disease paired with a biomarker of therapeutic activity | 🖼🧊📄§ | 2026-02-10 | 2040-09-04 | 0 | 31 |
| 12544435 | Neisserial surface protein a (NSPA) variants and methods of use thereof | 🖼🧊📄§ | 2026-02-10 | 2041-08-06 | 0 | 31 |
| 12544404 | Compositions and methods for treating bone injury | 🖼🧊📄§ | 2026-02-10 | 2039-09-17 | 0 | 31 |
| 12544403 | Methods to treat mitochondrial-associated dysfunctions or diseases | 🖼🧊📄§ | 2026-02-10 | 2040-01-10 | 0 | 31 |
| 12544440 | IL-36 secreting immunoresponsive cells and uses thereof | 🖼🧊📄§ | 2026-02-10 | 2043-08-10 | 0 | 31 |
| 12544454 | Reduced graphene oxide (rGO) based drug carrier systems | 🖼🧊📄§ | 2026-02-10 | 2041-12-24 | 0 | 31 |
| 12548651 | Identification of clonal neoantigens and uses thereof | 🖼🧊📄§ | 2026-02-10 | 2042-10-11 | 0 | 31 |
| 12544443 | Photodynamic therapy comprising two light exposures at different wavelengths | 🖼🧊📄§ | 2026-02-10 | 2043-03-22 | 0 | 31 |
| 12544387 | Methods and compositions for testosterone production | 🖼🧊📄§ | 2026-02-10 | 2045-06-06 | 0 | 31 |
| 12544366 | Combination of endocannabinoid and mTOR inhibitors in the treatment of neuroendocrine neoplasms | 🖼🧊📄§ | 2026-02-10 | 2043-05-17 | 0 | 31 |
| 12545727 | Antibodies specific to human Nectin-2 | 🖼🧊📄§ | 2026-02-10 | 2040-01-13 | 0 | 31 |
| 12545948 | Identification of novel loci in asthma and methods of use thereof for the diagnosis and treatment of asthma | 🖼🧊📄§ | 2026-02-10 | 2037-07-21 | 0 | 31 |
| 12545709 | Chimeric filovirus vaccines | 🖼🧊📄§ | 2026-02-10 | 2040-09-04 | 0 | 31 |
| 12545738 | Canine interleukin-4 receptor alpha antibodies | 🖼🧊📄§ | 2026-02-10 | 2040-12-18 | 0 | 31 |
| 12544384 | Antibiotic conjugates | 🖼🧊📄§ | 2026-02-10 | 2038-08-09 | 0 | 31 |
| 12545725 | Anti-PACAP antibodies, nucleic acids and methods of making thereof | 🖼🧊📄§ | 2026-02-10 | 2042-04-19 | 0 | 31 |
| 12544458 | PAH-modulating compositions and methods | 🖼🧊📄§ | 2026-02-10 | 2043-10-26 | 0 | 31 |
| 12544362 | Methods of treating acute respiratory distress syndrome with activators of Tie-2 | 🖼🧊📄§ | 2026-02-10 | 2041-05-20 | 0 | 31 |
| 12544413 | Composition with antibacterial and re-epithelializing action including probiotics | 🖼🧊📄§ | 2026-02-10 | 2040-06-18 | 0 | 31 |
| 12545722 | Pharmaceutical compositions targeting immune-mediated processes in neurodegenerative disease | 🖼🧊📄§ | 2026-02-10 | 2044-04-29 | 0 | 31 |
| 12544426 | Combination therapy with CD13-targeted chimeric proteins or chimeric protein complexes | 🖼🧊📄§ | 2026-02-10 | 2040-06-18 | 0 | 31 |